Fisher Asset Management, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 213 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
Fisher Asset Management, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$497,989
-1.8%
12,4280.0%0.00%
Q1 2023$507,186
+62904.5%
12,428
-40.4%
0.00%
-100.0%
Q4 2022$805
-99.9%
20,858
+0.3%
0.00%0.0%
Q3 2022$1,107,000
-8.7%
20,8040.0%0.00%0.0%
Q2 2022$1,213,000
-23.3%
20,804
+0.4%
0.00%0.0%
Q1 2022$1,581,000
+26.8%
20,7190.0%0.00%0.0%
Q4 2021$1,247,000
+7.1%
20,719
-0.3%
0.00%0.0%
Q3 2021$1,164,000
+20.4%
20,787
+30.4%
0.00%0.0%
Q2 2021$967,000
-13.5%
15,940
-0.1%
0.00%0.0%
Q1 2021$1,118,000
+6.6%
15,950
-9.0%
0.00%0.0%
Q4 2020$1,049,000
+12.0%
17,532
+12.5%
0.00%0.0%
Q3 2020$937,000
-20.8%
15,584
-30.9%
0.00%0.0%
Q2 2020$1,183,000
+35.0%
22,552
-13.7%
0.00%0.0%
Q1 2020$876,000
-26.2%
26,117
-0.3%
0.00%0.0%
Q4 2019$1,187,000
+1.5%
26,196
-14.7%
0.00%0.0%
Q3 2019$1,169,000
+385.1%
30,704
+481.3%
0.00%
Q4 2017$241,000
-19.1%
5,282
-15.6%
0.00%
Q2 2017$298,000
+4.6%
6,2570.0%0.00%
Q1 2017$285,000
+32.6%
6,257
-0.4%
0.00%
Q3 2016$215,000
-4.9%
6,282
+1.4%
0.00%
Q2 2016$226,000
-43.5%
6,1970.0%0.00%
-100.0%
Q1 2016$400,000
-16.0%
6,1970.0%0.00%0.0%
Q4 2015$476,000
+94.3%
6,197
+4.2%
0.00%0.0%
Q3 2015$245,000
-27.7%
5,950
+24.0%
0.00%0.0%
Q2 2015$339,000
-20.4%
4,8000.0%0.00%0.0%
Q1 2015$426,0000.0%4,8000.0%0.00%0.0%
Q4 2014$426,0004,8000.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders